PML-RARA (Promyelocytic Leukemia/Retinoic Acid Receptor Alpha) Translocation, t(15;17) Analysis
Tropheryma whipplei, Molecular
HLA-B27 Genotyping, Ankylosing Spondylitis
Cancer Antigen (CA) 19-9, Peritoneal Fluid
Rickettsia Antibody Panel, IgG and IgM
MDMA, Urine
Antithrombin Activity
Hemoglobin A1c
Electrophoresis, Protein, CSF
HLA Class II DR, DQ and DP Genotyping (HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
MEK1 Mutation Analysis, Melanoma
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
MEK1 Mutation Analysis, Melanoma
Medical Test
Methodology
Access to
MEK1 Mutation Analysis, Melanoma
is restricted.
Sign up now